Not logged in
  • Log in
    Membership (40247+) Group hosting [?] Wiki
    Franklin Award

    About bioinformatics
    Bioinformatics training
    Bioinformatics jobs

    All information groups
    Online databases Online analysis tools Online education tools More tools

    All software groups
    FTP repository
    SVN & CVS repositories [?]
    Mailing lists

    News & Commentary
  • Submit
  • Archives
  • Subscribe

  • Jobs Forum
    (Career Center)
  • Submit
  • Archives
  • Subscribe
  • News & Commentary - Message forums

    Open Access: Bio-IT World: Interference: A CRISPR patent dispute roadmap
    Submitted by J.W. Bizzaro; posted on Tuesday, January 10, 2017



    Emmanuelle Charpentier and Jennifer Doudna have become world renowned for their discoveries and development involving CRISPR/Cas9, a gene-editing technology that has been called "one of the most important genetic inventions of our time".

    In 2014, the duo received the 2015 Breakthrough Prize in Life Sciences. The following year, Charpentier and Doudna were also co-awarded the €50,000 Princess of Asturias Award of Technical and Scientific Research – commonly referred to as the "Spanish Nobel Prize". The pair also garnered a nomination for the actual Nobel Prize in Chemistry.

    Meanwhile, on April 15, 2014, another genetic researcher, Feng Zhang, was awarded something potentially much more valuable than the Nobel Prize: a patent by the United States Patent and Trademark Office (USPTO) for the very same thing for which Charpentier and Doudna have received so many accolades: using CRISPR/Cas9 to edit genes.

    Expanded view | Monitor forum | Save place

    Start a new thread:
    You have to be logged in to post a reply.


    Copyright © 2018 · Scilico, LLC